Literature DB >> 19011638

Chemo-enzymatic fluorination of unactivated organic compounds.

Andrea Rentmeister1, Frances H Arnold, Rudi Fasan.   

Abstract

Fluorination has gained an increasingly important role in drug discovery and development. Here we describe a versatile strategy that combines cytochrome P450-catalyzed oxygenation with deoxofluorination to achieve mono- and polyfluorination of nonreactive sites in a variety of organic scaffolds. This procedure was applied for the rapid identification of fluorinated drug derivatives with enhanced membrane permeability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19011638      PMCID: PMC2713661          DOI: 10.1038/nchembio.128

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  14 in total

Review 1.  Metabolism of fluorine-containing drugs.

Authors:  B K Park; N R Kitteringham; P M O'Neill
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

2.  Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.

Authors:  Miklos Feher; Jonathan M Schmidt
Journal:  J Chem Inf Comput Sci       Date:  2003 Jan-Feb

Review 3.  Asymmetric fluorination, trifluoromethylation, and perfluoroalkylation reactions.

Authors:  Jun-An Ma; Dominique Cahard
Journal:  Chem Rev       Date:  2004-12       Impact factor: 60.622

4.  Catalytic asymmetric fluorinations.

Authors:  Carla Bobbio; Véronique Gouverneur
Journal:  Org Biomol Chem       Date:  2006-05-03       Impact factor: 3.876

5.  Evolutionary history of a specialized p450 propane monooxygenase.

Authors:  Rudi Fasan; Yergalem T Meharenna; Christopher D Snow; Thomas L Poulos; Frances H Arnold
Journal:  J Mol Biol       Date:  2008-06-28       Impact factor: 5.469

6.  Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C.

Authors:  M A Hamman; G A Thompson; S D Hall
Journal:  Biochem Pharmacol       Date:  1997-07-01       Impact factor: 5.858

Review 7.  Selective modulation of Abeta42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyond.

Authors:  Stefanie Leuchtenberger; Dirk Beher; Sascha Weggen
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 8.  Fluorine in medicinal chemistry.

Authors:  Hans-Joachim Böhm; David Banner; Stefanie Bendels; Manfred Kansy; Bernd Kuhn; Klaus Müller; Ulrike Obst-Sander; Martin Stahl
Journal:  Chembiochem       Date:  2004-05-03       Impact factor: 3.164

9.  Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.

Authors:  Tuck Seng Wong; Frances H Arnold; Ulrich Schwaneberg
Journal:  Biotechnol Bioeng       Date:  2004-02-05       Impact factor: 4.530

Review 10.  Fluorine in pharmaceuticals: looking beyond intuition.

Authors:  Klaus Müller; Christoph Faeh; François Diederich
Journal:  Science       Date:  2007-09-28       Impact factor: 47.728

View more
  26 in total

Review 1.  Enzymatic functionalization of carbon-hydrogen bonds.

Authors:  Jared C Lewis; Pedro S Coelho; Frances H Arnold
Journal:  Chem Soc Rev       Date:  2010-11-15       Impact factor: 54.564

2.  Engineering fluorination.

Authors:  Graham Sandford
Journal:  Nat Chem Biol       Date:  2009-01       Impact factor: 15.040

3.  Expanding the repertoire of biofuel alternatives through metabolic pathway evolution.

Authors:  Mattheos A G Koffas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

4.  Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.

Authors:  Joshua N Kolev; Kristen M O'Dwyer; Craig T Jordan; Rudi Fasan
Journal:  ACS Chem Biol       Date:  2013-11-08       Impact factor: 5.100

5.  Late-Stage Diversification of Biologically Active Molecules via Chemoenzymatic C-H Functionalization.

Authors:  Landon J Durak; James T Payne; Jared C Lewis
Journal:  ACS Catal       Date:  2016-01-25       Impact factor: 13.084

6.  Combined Photoredox/Enzymatic C-H Benzylic Hydroxylations.

Authors:  Rick C Betori; Catherine M May; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-26       Impact factor: 15.336

7.  Stabilization of the Reductase Domain in the Catalytically Self-Sufficient Cytochrome P450BM3 by Consensus-Guided Mutagenesis.

Authors:  Gloria Saab-Rincón; Hanan Alwaseem; Valeria Guzmán-Luna; Leticia Olvera; Rudi Fasan
Journal:  Chembiochem       Date:  2018-02-12       Impact factor: 3.164

8.  Catalyst-Controlled Site-Selective Bond Activation.

Authors:  John F Hartwig
Journal:  Acc Chem Res       Date:  2017-03-21       Impact factor: 22.384

9.  Enantioselective Total Synthesis of Nigelladine A via Late-Stage C-H Oxidation Enabled by an Engineered P450 Enzyme.

Authors:  Steven A Loskot; David K Romney; Frances H Arnold; Brian M Stoltz
Journal:  J Am Chem Soc       Date:  2017-07-24       Impact factor: 15.419

10.  Selective oxidation of carbolide C-H bonds by an engineered macrolide P450 mono-oxygenase.

Authors:  Shengying Li; Mani Raj Chaulagain; Allison R Knauff; Larissa M Podust; John Montgomery; David H Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.